Taiwan FDA registration a292d7cbcaf2cf6b5a7ebbc687c730b1

Quirk's superior simple blood glucose monitoring system

TW: 艾奎克卓越簡易血糖監測系統

Taiwan·Risk Class 2·Shengyao Technology Co., Ltd. forest factory·Registered Jan 12, 2022 – Jan 12, 2027Active

Registration details

Analysis ID: a292d7cbcaf2cf6b5a7ebbc687c730b1

Company information

Manufacturer: Shengyao Technology Co., Ltd. forest factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Shengyao Technology Co., Ltd. forest factory

Product details

Intended Use: This product is used for in vitro diagnostic quantitative detection of blood glucose in microvascular whole blood (fingertip) or venous blood samples. This product is suitable for diabetic patients at home and professional use.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1345 Glucose Test System
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Jan 12, 2022
Expiry Date: Jan 12, 2027

About this record

Access comprehensive regulatory information for Quirk's superior simple blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a292d7cbcaf2cf6b5a7ebbc687c730b1 and manufactured by Shengyao Technology Co., Ltd. forest factory. The authorized representative in Taiwan is Shengyao Technology Co., Ltd. forest factory.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.